August 2018—Luxembourg-based Advanced Biological Laboratories has signed a definitive agreement to acquire CDL Pharma. CDL Pharma, headquartered in France, provides biological sample management solutions in clinical research for pharmaceutical laboratories, contact research organizations, biotechnology companies, and others. The company also manufactures in vitro diagnostic kits in the fields of immunology, molecular biology, and infectious diseases.
“We are delighted to welcome CDL Pharma and are glad to extend ABL products and services to new areas including clinical research and in vitro diagnostic kits manufacturing. This acquisition is an important asset for ABL to keep targeting ambitious milestones like completing its products portfolio with CE IVD assays,” Chalom Sayada, MD, PhD, CEO of ABL, said in a press release.
Advanced Biological Laboratories, +352 26 38 96 76